Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalfampridine for Visual Function in MS Optic Neuritis
NCT01337986Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- May 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dalfampridine in multiple sclerosis (MS), optic neuritis (ON), sponsored by Washington University School of Medicine. Started May 2011; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)optic neuritis (ON)
Beyond the preview
Go deeper on NCT01337986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01337986.